Lymphoma survivors with chronic fatigue participating in a multidisciplinary intervention program experienced a beneficial ...

DelveInsight's Indolent Lymphoma Market Insights report includes a comprehensive understanding of current treatment practices ...

Cancer diagnosis and treatment redefine normality, with chronic conditions like follicular lymphoma posing ongoing challenges ...

In a matched analysis involving 110 patients with transformed indolent non-Hodgkin lymphoma (TriNHL) and 391 patients with de ...

A study published in Cancer Discovery finds that combining an epigenetic therapy with an anti-PD-1 antibody, which uses the ...

In the global intention-to-treat population, Pola-R-CHP showed significant progression-free survival benefit over R-CHOP ...

FDA fast-tracks EO2463 immunotherapy for follicular lymphoma, promising a new treatment option backed by positive trial data ...

DelveInsight’s, “Mantle Cell Lymphoma- Pipeline Insight, 2025” report provides comprehensive insights about 20+ companies and ...

Covers low tumor burden “watch-and-wait” setting, an unmet medical needRegistrational Phase 3 watch-and-wait to start in 2026EO2463 has broad potential to treat hemato-oncology indications Paris, ...

After undergoing treatment for Stage 2 Hodgkins lymphoma, Hardee Bhavsar is on a journey to cross items off her bucket list ...

Everyday, more than 500 Central New Yorks will come to the Upstate Cancer Center or another location to get chemo, radiation ...

Boo Halloween Party benefiting The Leukemia & Lymphoma Society returns on Friday, Oct. 31. Join the spook-tacular event at B ...